Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats

Brain Research

Volumn 1130, Issue 1, 2007, Pages 206-213

  Hrnkova, Miroslava ^a   Zilka, Norbert ^a,b   Minichova, Zuzana ^a   Koson, Peter ^a   Novak, Michal ^a,b  

^a INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

^b Axon Neuroscience Forschungs und Entwicklungs GmbH   (Austria)

Author keywords

Alzheimer's disease; Neurobehavioural assessment; Tau truncation; Transgenic rat

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LEARNING; MAZE TEST; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORIMOTOR FUNCTION; SPATIAL MEMORY; TRANSGENIC RAT;

ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; HUMANS; MALE; MAZE LEARNING; MEMORY; MOTOR ACTIVITY; RATS; RATS, INBRED STRAINS; REFLEX; SPACE PERCEPTION; SPATIAL BEHAVIOR; TAU PROTEINS;

ANIMALIA; RATTUS;

EID: 33845966445     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.10.085     Document Type: Article

References (17)

1. Binder L.I., Guillozet-Bongaarts A.L., Garcia-Sierra F., and Berry R.W. Tau, tangles, and Alzheimer's disease. Biochim. Biophys. Acta 3 (2005) 216-223 (Review)
2. Combs D.J., and D'Alecy L.G. Motor performance in rats exposed to severe forebrain ischemia: effect of fasting and 1,3-butanediol. Stroke 18 (1987) 503-511
3. Compton D.M., Griffith H.R., McDaniel W.F., Foster R.A., and Davis B.K. The flexible use of multiple cue relationships in spatial navigation: a comparison of water maze performance following hippocampal, medial septal, prefrontal cortex, or posterior parietal cortex lesions. Neurobiol. Learn Mem. 68 (1997) 117-132
4. Feeney D.M., Gonzalez A., and Law W.A. Amphetamine, haloperidol and experience interact to affect rate of recovery after motor cortex injury. Science 217 (1982) 855-857
5. Goldstein L.B., and Davis J.N. Influence of lesion size and location on amphetamine-facilitated recovery of beam-walking in rats. Behav. Neurosci. 104 (1990) 320-327
6. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., and Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 4913-4917
7. Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioural and physiologic state of the mouse. Psychopharmacologia 13 (1968) 222-257
8. Morris R.GM., Garrud P., Rawlings J.N., and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297 (1982) 681-683
9. Novak M. Truncated tau protein as a new marker for Alzheimer's disease. Acta Virol. 38 (1994) 173-189 (Review)
10. Novak M., Jakes R., Edwards P.C., Milstein C., and Wischik C.M. Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 5837-5841
11. Novak M., Kabat J., and Wischik C.M. Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J. 12 (1993) 365-370
12. Prut L., and Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviours: a review. Eur. J. Pharmacol. 463 (2003) 3-33
13. Rogers D.C., Fisher E.M., Brown S.D., Peters J., Hunter A.J., and Martin J.E. Behavioural and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome 8 (1997) 711-713
14. Wischik C.M., Novak M., Thogersen H.C., Edwards P.C., Runswick M.J., Jakes R., Walker J.E., Milstein C., Roth M., and Klug A. Isolation of a fragment of tau derived from the core of paired helical filament of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 4506-4510
15. Wischik C.M., Novak M., Edwards P.C., Klug A., Tichelaar W., and Crowther R.A. Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 4884-4888
16. Zausinger S., Hungerhuber E., Baethmann A., Reulen H.J., and Schmid-Elsaesser R. Neurological impairment in rats after transient middle cerebral artery occlusion: a comparative study under various treatment paradigms. Brain Res. 863 (2000) 94-105
17. Zilka N., Filipcik P., Koson P., Fialova L., Skrabana R., Zilkova M., Rolkova G., Kontsekova E., and Novak M. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett. 580 (2006) 3582-3588